A Prospective Double Blind Placebo Controlled study of Repetitive Transcranial Magnetic Stimulation for PTSD

Based on the public registry summary, this study is trying to understand: The purpose of this study is to determine if transcranial magnetic stimulation at 1 HZ to the right frontal cortex will decrease the symptoms of post-traumatic stress disorder (PTSD). The study team can confirm the exact objective and what it means for you.

This appears to be a device / app / digital / technology study involving transcranial magnetic stimulation. The listed phase is PHASE4. Ask the study team what that means in practice for safety, monitoring, and criteria.

This study may concern people with ptsd; age range: From 18 Years to 75 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

You may need to use a device, app, or digital tool for a defined period. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

If the study uses a device, app, or digital tool, check what data is collected, who can access it, how often you need to use it, and what happens if the tool detects a concerning signal. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

This study is sponsored by White River Junction Veterans Affairs Medical Center, which appears to be a hospital or academic medical center. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

The recruitment status is not clearly listed. Check the official registry or contact the study team. The registry lists an estimated enrollment of 40 participants.